122 related articles for article (PubMed ID: 8025205)
1. Protection from BB rat diabetes by the platelet-activating factor inhibitor BN50730.
Jobe LW; Ubungen R; Goodner CJ; Baskin DG; Braquet P; Lernmark A
Autoimmunity; 1993; 16(4):259-66. PubMed ID: 8025205
[TBL] [Abstract][Full Text] [Related]
2. Effects of ginkgolide B, a platelet-activating factor inhibitor on insulitis in the spontaneously diabetic BB rat.
Beck JC; Goodner CJ; Wilson C; Wilson D; Glidden D; Baskin DG; Lernmark A; Braquet P
Autoimmunity; 1991; 9(3):225-35. PubMed ID: 1777555
[TBL] [Abstract][Full Text] [Related]
3. Long-term prophylactic insulin treatment can prevent spontaneous diabetes and thyroiditis development in the diabetes-prone bio-breeding rat, while short-term treatment is ineffective.
Visser J; Klatter F; Vis L; Groen H; Strubbe J; Rozing J
Eur J Endocrinol; 2003 Sep; 149(3):223-9. PubMed ID: 12943525
[TBL] [Abstract][Full Text] [Related]
4. Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats.
Buschard K; Pedersen C; Hansen SV; Hageman I; Aaen K; Bendtzen K
Autoimmunity; 1992; 14(2):101-4. PubMed ID: 1303676
[TBL] [Abstract][Full Text] [Related]
5. Initiation of autoimmune type 1 diabetes and molecular cloning of a gene encoding for islet cell-specific 37kd autoantigen.
Jun HS; Yoon JW
Adv Exp Med Biol; 1994; 347():207-20. PubMed ID: 7976732
[TBL] [Abstract][Full Text] [Related]
6. Rel B is an early marker of autoimmune islet inflammation in the biobreeding (BB) rat.
Bieg S; Simonson W; Ellefsen K; Lernmark A
Pancreas; 2000 Jan; 20(1):47-54. PubMed ID: 10630383
[TBL] [Abstract][Full Text] [Related]
7. Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats.
Zipris D; Greiner DL; Malkani S; Whalen B; Mordes JP; Rossini AA
J Immunol; 1996 Feb; 156(3):1315-21. PubMed ID: 8558012
[TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulatory azaspirane, SK&F 106610.
Rabinovitch A; Suarez WL; Qin HY; Power RF; Badger AM
J Autoimmun; 1993 Feb; 6(1):39-49. PubMed ID: 8457285
[TBL] [Abstract][Full Text] [Related]
9. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.
Dotta F; Eisenbarth GS
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S85-95. PubMed ID: 2642771
[TBL] [Abstract][Full Text] [Related]
10. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant.
Sadelain MW; Qin HY; Sumoski W; Parfrey N; Singh B; Rabinovitch A
J Autoimmun; 1990 Dec; 3(6):671-80. PubMed ID: 2088390
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and disease progression in the spontaneously diabetic BB/S rat.
Lally FJ; Ratcliff H; Bone AJ
Diabetologia; 2001 Mar; 44(3):320-4. PubMed ID: 11317663
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.
Lee ES; Jiang J; Sund GC; Simonson WT; Graham J; Dietsch G; Schimpf B; Bieg S; Peterman G; Lernmark A
Diabetes; 1999 Jan; 48(1):43-9. PubMed ID: 9892221
[TBL] [Abstract][Full Text] [Related]
13. Studies on autoimmunity for initiation of beta-cell destruction. X. Delayed expression of a membrane-bound islet cell-specific 38 kDa autoantigen that precedes insulitis and diabetes in the diabetes-prone BB rat.
Ko IY; Jun HS; Kim GS; Yoon JW
Diabetologia; 1994 May; 37(5):460-5. PubMed ID: 8056182
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat.
Kover KL; Geng Z; Hess DM; Benjamin CD; Moore WV
Diabetes; 2000 Oct; 49(10):1666-70. PubMed ID: 11016450
[TBL] [Abstract][Full Text] [Related]
15. Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth.
Posselt AM; Barker CF; Friedman AL; Naji A
Science; 1992 May; 256(5061):1321-4. PubMed ID: 1598576
[TBL] [Abstract][Full Text] [Related]
16. New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists.
Braquet P; Esanu A
Agents Actions; 1991 Jan; 32(1-2):34-6. PubMed ID: 2058466
[No Abstract] [Full Text] [Related]
17. Prevention of diabetes in BB/Wor rats by intrathymic islet injection.
Koevary SB; Blomberg M
J Clin Invest; 1992 Feb; 89(2):512-6. PubMed ID: 1737841
[TBL] [Abstract][Full Text] [Related]
18. Prevention of diabetes in BB/Wor rats by injection of peritoneal exudate cells cultured in the presence of transforming growth factor beta (TGF-beta) and islet cells.
Koevary SB
Diabetes Res; 1994; 27(1):1-14. PubMed ID: 7648792
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin mitigates β-cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat.
Baena-Nieto G; Lomas-Romero IM; Mateos RM; Leal-Cosme N; Perez-Arana G; Aguilar-Diosdado M; Segundo C; Lechuga-Sancho AM
Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27103341
[TBL] [Abstract][Full Text] [Related]
20. Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats.
Gottlieb PA; Handler ES; Appel MC; Greiner DL; Mordes JP; Rossini AA
Diabetologia; 1991 May; 34(5):296-300. PubMed ID: 1864483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
